Golden Meditech Holdings Ltd (801):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Golden Meditech Holdings Ltd (801) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11484
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:香港
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Golden Meditech Holdings Ltd (Golden Meditech) is a medical equipment provider that provides blood stem cells storage and hospital management solutions. The company provides autologous blood recovery systems. It offers hospital management, medical insurance administration and blood bank services, among others. Golden Meditech’s products are used for blood purification, recovery and treatment, among others. The company also provides blood bank for cord blood stem cells storage, and investments in the healthcare industry. It markets its products through a network of distributors in China and Hong Kong. Golden Meditech is headquartered in Hong Kong.

Golden Meditech Holdings Ltd (801) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Equity Offering 13
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Debt Offering 15
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For US$50 Million 17
Acquisition 18
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For US$28 Million 24
Golden Meditech Holdings Ltd – Key Competitors 25
Golden Meditech Holdings Ltd – Key Employees 26
Golden Meditech Holdings Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Joint Venture 28
Recent Developments 29
Financial Announcements 29
Jun 27, 2018: Golden Meditech Announces FY2017/2018 Annual Results 29
Jun 25, 2018: Golden Meditech Holdings: Positive Profit Alert 31
Nov 30, 2017: Golden Meditech Announces FY2017/2018 Interim Results 32
Jun 28, 2017: Golden Meditech Announces FY2016/2017 Annual Results 34
Corporate Communications 36
Apr 26, 2018: Golden Meditech: Re-designation of Directors and Changes of Members of Board Committees 36
Apr 16, 2018: Golden Meditech’s Associate, Cellenkos Appoints Alick Sun as Corporate & Business Development SVP 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Golden Meditech Enters into Partnership Agreement with GE Healthcare 11
Golden Meditech and MD Anderson to Form Joint Venture 12
Golden Meditech to Raise up to USD18 Million in Private Placement of Shares 13
Golden Meditech to Raise Funds through Rights Offering of Shares 14
Golden Meditech Raises USD65 Million in Private Placement of 7% Notes Due 2017 15
Golden Meditech to Raises USD20 Million in Convertible Notes Offering 16
China Cord Blood Completes Private Placement Of Note For US$50 Million 17
Nanjing Yingpeng Huikang Medical Acquires 65.4% Stake in China Cord Blood 18
Golden Meditech Plans to Acquire Remaining Stake in China Cord Blood 20
Golden Meditech to Acquire Remaining Stake in GM Hospital for USD21 Million 22
Golden Meditech Increases Stake In GM Hospital Group For US$28 Million 24
Golden Meditech Holdings Ltd, Key Competitors 25
Golden Meditech Holdings Ltd, Key Employees 26
Golden Meditech Holdings Ltd, Other Locations 27
Golden Meditech Holdings Ltd, Subsidiaries 27
Golden Meditech Holdings Ltd, Joint Venture 28

List of Figures
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Golden Meditech Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Golden Meditech Holdings Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Golden Meditech Holdings Ltd (801):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Heathrow Airport Holdings Ltd:企業の戦略的SWOT分析
    Heathrow Airport Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Atwood Oceanics Inc-石油・ガス分野:企業M&A・提携分析
    Summary Atwood Oceanics, Inc. (Atwood) is an offshore drilling contractor, which offers drilling and completion solutions to the oil and gas industry. The company owns a diversified fleet of mobile offshore drilling units in the US Gulf of Mexico, the Mediterranean Sea, offshore West Africa, offshor …
  • M3 Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary M3 Biotechnology Inc (M3 Biotech) is a clinical stage biotech company that focuses on regenerative medicine. The company is developing clinical programs for the treatment of Alzheimer, MS, Parkinson and Alzheimerdisease (oral) among others. It utilizes discovery platform and develops small m …
  • Groupe SEB S.A. (SK):企業の財務・戦略的SWOT分析
    Groupe SEB S.A. (SK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Nintendo Co Ltd (7974):企業の財務・戦略的SWOT分析
    Nintendo Co Ltd (7974) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Medherant Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Medherant Ltd (Medherant) is a transdermal drug delivery patch company. The company develops and commercializes novel technologies for delivery of drugs through the skin using expertise in bioadhesives and polymer chemistry to treat pain, Alzheimer's disease, and for smoking cessation, hormo …
  • Olympus Corporation:企業の戦略・SWOT・財務分析
    Olympus Corporation - Strategy, SWOT and Corporate Finance Report Summary Olympus Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …
  • Ashok Leyland Ltd (ASHOKLEY):企業の財務・戦略的SWOT分析
    Ashok Leyland Ltd (ASHOKLEY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • PQ Group Holdings Inc (PQG):企業の財務・戦略的SWOT分析
    PQ Group Holdings Inc (PQG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Liberty Global plc:企業のM&A・事業提携・投資動向
    Liberty Global plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Liberty Global plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Fortis Inc.:企業の戦略・SWOT・財務情報
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Givaudan SA:企業の戦略・SWOT・財務情報
    Givaudan SA - Strategy, SWOT and Corporate Finance Report Summary Givaudan SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Anhui Construction Engineering Group Co., Ltd.:企業の戦略・SWOT・財務情報
    Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anhui Construction Engineering Group Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Crescendo Biologics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company’s pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, …
  • iVascular SLU:製品パイプライン分析
    Summary iVascular SLU (iVascular) designs, develops and manufactures advanced medical devices and therapies for the treatment of disorders of the cardiovascular system. It offers portfolio of products in the fields of interventional cardiology, endovascular intervention and interventional neuroradio …
  • Swiss Re Group:企業のM&A・事業提携・投資動向
    Swiss Re Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Re Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Bangkok Chain Hospital Public Co Ltd (BCH):企業の財務・戦略的SWOT分析
    Bangkok Chain Hospital Public Co Ltd (BCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆